Frontier Biotechnologies today shared real-world evidence of Albuvirtide (ABT)-based two drug regimen's safety and efficacy for hospitalized AIDS patients at the European AIDS Clinical Society (EACS) Conference.
Thermo Fisher Scientific Inc., the world leader in serving science, announced collaboration with China Frontier Biotechnologies Inc. to develop a novel treatment for human immunodeficiency virus (HIV).